Foresee Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	13,092	12,698	11,995	13,062	10,797	14,047
Market Cap Growth	31.08%	5.86%	-8.16%	20.98%	-23.14%	34.12%
Enterprise Value	12,599	12,190	11,645	11,754	9,869	12,654
Last Close Price	83.10	80.60	77.50	96.18	90.37	118.16
PS Ratio	32.64	29.44	28.65	66.97	35.81	62.15
PB Ratio	9.39	13.66	7.50	10.50	11.86	10.64
P/TBV Ratio	10.16	15.51	8.10	11.69	14.03	12.06
EV/Sales Ratio	31.41	28.26	27.81	60.27	32.73	55.98
Debt / Equity Ratio	0.29	0.25	0.16	0.18	0.05	0.01
Net Debt / Equity Ratio	-0.35	-0.27	-0.69	-0.75	-0.71	-0.95
Net Debt / EBITDA Ratio	0.74	0.31	1.09	0.98	1.51	2.51
Net Debt / FCF Ratio	0.63	0.29	0.84	1.00	2.23	5.69
Asset Turnover	0.22	0.25	0.21	0.12	0.21	0.12
Inventory Turnover	0.90	0.83	1.15	0.54	0.25	1.73
Quick Ratio	11.02	1.89	3.63	2.65	5.54	17.12
Current Ratio	13.61	3.44	4.62	3.38	7.08	17.51
Return on Equity (ROE)	-13.45%	-69.85%	-76.04%	-96.17%	-42.38%	-36.15%
Return on Assets (ROA)	-24.41%	-31.07%	-33.57%	-39.79%	-19.92%	-18.00%
Return on Capital Employed (ROCE)	-38.50%	-84.20%	-61.10%	-72.50%	-40.00%	-34.40%
Earnings Yield	-1.40%	-6.96%	-9.01%	-7.93%	-4.38%	-4.05%
FCF Yield	-5.93%	-6.66%	-11.03%	-7.15%	-2.70%	-1.57%
Buyback Yield / Dilution	-9.70%	-12.80%	-7.89%	-7.82%	-0.57%	-15.74%